Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ALIM

Alimera Sciences (ALIM)

Alimera Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALIM
DateTimeSourceHeadlineSymbolCompany
06/24/20245:50AMGlobeNewswire Inc.ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera SciencesNASDAQ:ALIMAlimera Sciences Inc
06/04/20243:30PMGlobeNewswire Inc.Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
05/16/20244:06PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ALIMAlimera Sciences Inc
05/14/20244:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALIMAlimera Sciences Inc
05/14/20247:46AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
05/14/20246:30AMGlobeNewswire Inc.Alimera Sciences Reports First Quarter 2024 ResultsNASDAQ:ALIMAlimera Sciences Inc
05/07/20247:00AMGlobeNewswire Inc.Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress ConferencesNASDAQ:ALIMAlimera Sciences Inc
04/30/20247:00AMGlobeNewswire Inc.Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateNASDAQ:ALIMAlimera Sciences Inc
03/20/20247:00AMGlobeNewswire Inc.Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
03/19/20247:00AMGlobeNewswire Inc.Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina NetworkNASDAQ:ALIMAlimera Sciences Inc
03/08/20244:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
03/07/20247:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
03/07/20246:30AMGlobeNewswire Inc.Alimera Sciences Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:ALIMAlimera Sciences Inc
02/29/20247:00AMGlobeNewswire Inc.Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate UpdateNASDAQ:ALIMAlimera Sciences Inc
02/13/20243:43PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
02/13/20243:24PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
02/13/20242:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
02/09/20244:25PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
02/09/20244:14PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
02/09/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
02/08/20247:00AMGlobeNewswire Inc.The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®NASDAQ:ALIMAlimera Sciences Inc
01/11/202411:49AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
01/04/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
01/04/20243:02PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
01/04/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
01/04/20247:00AMGlobeNewswire Inc.Alimera Completes Recruitment for the Synchronicity StudyNASDAQ:ALIMAlimera Sciences Inc
01/02/20247:00AMGlobeNewswire Inc.Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
12/13/20234:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
12/13/20234:19PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
12/12/20234:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ALIM